IBDEI0XW ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16734,0)
 ;;=386.30^^92^941^41
 ;;^UTILITY(U,$J,358.3,16734,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16734,1,4,0)
 ;;=4^386.30
 ;;^UTILITY(U,$J,358.3,16734,1,5,0)
 ;;=5^Labyrinthitis NOS
 ;;^UTILITY(U,$J,358.3,16734,2)
 ;;=^67891
 ;;^UTILITY(U,$J,358.3,16735,0)
 ;;=088.81^^92^941^42
 ;;^UTILITY(U,$J,358.3,16735,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16735,1,4,0)
 ;;=4^088.81
 ;;^UTILITY(U,$J,358.3,16735,1,5,0)
 ;;=5^Lyme Disease
 ;;^UTILITY(U,$J,358.3,16735,2)
 ;;=^72315
 ;;^UTILITY(U,$J,358.3,16736,0)
 ;;=785.6^^92^941^43
 ;;^UTILITY(U,$J,358.3,16736,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16736,1,4,0)
 ;;=4^785.6
 ;;^UTILITY(U,$J,358.3,16736,1,5,0)
 ;;=5^Lymphadenopathy
 ;;^UTILITY(U,$J,358.3,16736,2)
 ;;=^72368
 ;;^UTILITY(U,$J,358.3,16737,0)
 ;;=031.0^^92^941^44
 ;;^UTILITY(U,$J,358.3,16737,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16737,1,4,0)
 ;;=4^031.0
 ;;^UTILITY(U,$J,358.3,16737,1,5,0)
 ;;=5^Mycobacteria,Atyp,Pulmonary
 ;;^UTILITY(U,$J,358.3,16737,2)
 ;;=^101018
 ;;^UTILITY(U,$J,358.3,16738,0)
 ;;=730.00^^92^941^46
 ;;^UTILITY(U,$J,358.3,16738,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16738,1,4,0)
 ;;=4^730.00
 ;;^UTILITY(U,$J,358.3,16738,1,5,0)
 ;;=5^Osteomyelitis,Acute Unsp
 ;;^UTILITY(U,$J,358.3,16738,2)
 ;;=^272612
 ;;^UTILITY(U,$J,358.3,16739,0)
 ;;=730.10^^92^941^47
 ;;^UTILITY(U,$J,358.3,16739,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16739,1,4,0)
 ;;=4^730.10
 ;;^UTILITY(U,$J,358.3,16739,1,5,0)
 ;;=5^Osteomyelitis,Chron Unsp
 ;;^UTILITY(U,$J,358.3,16739,2)
 ;;=^24427
 ;;^UTILITY(U,$J,358.3,16740,0)
 ;;=380.10^^92^941^48
 ;;^UTILITY(U,$J,358.3,16740,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16740,1,4,0)
 ;;=4^380.10
 ;;^UTILITY(U,$J,358.3,16740,1,5,0)
 ;;=5^Otitis Externa 
 ;;^UTILITY(U,$J,358.3,16740,2)
 ;;=380.10^62807
 ;;^UTILITY(U,$J,358.3,16741,0)
 ;;=382.9^^92^941^49
 ;;^UTILITY(U,$J,358.3,16741,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16741,1,4,0)
 ;;=4^382.9
 ;;^UTILITY(U,$J,358.3,16741,1,5,0)
 ;;=5^Otitis Media
 ;;^UTILITY(U,$J,358.3,16741,2)
 ;;=^123967
 ;;^UTILITY(U,$J,358.3,16742,0)
 ;;=614.9^^92^941^50
 ;;^UTILITY(U,$J,358.3,16742,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16742,1,4,0)
 ;;=4^614.9
 ;;^UTILITY(U,$J,358.3,16742,1,5,0)
 ;;=5^Pelvic Inflammatory Disease
 ;;^UTILITY(U,$J,358.3,16742,2)
 ;;=^3537
 ;;^UTILITY(U,$J,358.3,16743,0)
 ;;=486.^^92^941^52
 ;;^UTILITY(U,$J,358.3,16743,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16743,1,4,0)
 ;;=4^486.
 ;;^UTILITY(U,$J,358.3,16743,1,5,0)
 ;;=5^Pneumonia
 ;;^UTILITY(U,$J,358.3,16743,2)
 ;;=^95632
 ;;^UTILITY(U,$J,358.3,16744,0)
 ;;=136.3^^92^941^51
 ;;^UTILITY(U,$J,358.3,16744,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16744,1,4,0)
 ;;=4^136.3
 ;;^UTILITY(U,$J,358.3,16744,1,5,0)
 ;;=5^Pneumocystosis
 ;;^UTILITY(U,$J,358.3,16744,2)
 ;;=^95635
 ;;^UTILITY(U,$J,358.3,16745,0)
 ;;=601.9^^92^941^56
 ;;^UTILITY(U,$J,358.3,16745,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16745,1,4,0)
 ;;=4^601.9
 ;;^UTILITY(U,$J,358.3,16745,1,5,0)
 ;;=5^Prostatitis NOS
 ;;^UTILITY(U,$J,358.3,16745,2)
 ;;=^99489
 ;;^UTILITY(U,$J,358.3,16746,0)
 ;;=590.80^^92^941^57
 ;;^UTILITY(U,$J,358.3,16746,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16746,1,4,0)
 ;;=4^590.80
 ;;^UTILITY(U,$J,358.3,16746,1,5,0)
 ;;=5^Pyelonephritis NOS
 ;;^UTILITY(U,$J,358.3,16746,2)
 ;;=^101463
 ;;^UTILITY(U,$J,358.3,16747,0)
 ;;=711.00^^92^941^58
 ;;^UTILITY(U,$J,358.3,16747,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16747,1,4,0)
 ;;=4^711.00
 ;;^UTILITY(U,$J,358.3,16747,1,5,0)
 ;;=5^Septic Joint
 ;;^UTILITY(U,$J,358.3,16747,2)
 ;;=^263780
